MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Operating Expenses came in at $48.9 million in Q4 2025, down 7.54% YoY from $52.9 million in Q4 2024, and up 5.23% on a QoQ basis from $46.5 million in Q3 2025.
MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Operating Expenses data on file, last reported at $48.9 million in Q4 2025.
- Quarterly Operating Expenses fell 7.54% year-over-year to $48.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $187.4 million (down 5.13% YoY) and the FY2025 annual result came in at $187.4 million, down 5.13% from the prior year.
- Operating Expenses rose to $48.9 million in Q4 2025, from $46.5 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $52.9 million in Q4 2024 to a low of $25.6 million in Q2 2021.
- A 5-year average of $38.9 million and a median of $36.8 million in 2022 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2021 — Operating Expenses soared 118.16% — and 2025, when it slipped 8.81%.
- Tracing MGTX's Operating Expenses over 5 years: stood at $28.7 million in 2021, then rose by 24.48% to $35.8 million in 2022, then rose by 28.03% to $45.8 million in 2023, then increased by 15.47% to $52.9 million in 2024, then fell by 7.54% to $48.9 million in 2025.
- The last three Operating Expenses figures came in at $48.9 million (Q4 2025), $46.5 million (Q3 2025), and $48.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 48.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.89 Mn |
| Sep 30, 2025 | 46.46 Mn |
| Jun 30, 2025 | 48.48 Mn |
| Mar 31, 2025 | 43.52 Mn |
| Dec 31, 2024 | 52.88 Mn |
| Sep 30, 2024 | 50.95 Mn |
| Jun 30, 2024 | 46.19 Mn |
| Mar 31, 2024 | 47.47 Mn |
| Dec 31, 2023 | 45.79 Mn |
| Sep 30, 2023 | 37.87 Mn |
| Jun 30, 2023 | 32.33 Mn |
| Mar 31, 2023 | 35.09 Mn |
| Dec 31, 2022 | 35.77 Mn |
| Sep 30, 2022 | 27.62 Mn |
| Jun 30, 2022 | 34.52 Mn |
| Mar 31, 2022 | 34.37 Mn |
| Dec 31, 2021 | 28.73 Mn |
| Sep 30, 2021 | 29.50 Mn |
| Jun 30, 2021 | 25.60 Mn |
| Mar 31, 2021 | 26.63 Mn |